Operator: Good morning, everyone, and welcome to the IDEXX Laboratories' Fourth Quarter 2010 Earnings Conference Call. Just a reminder, today's conference is being recorded. Participating in the call this morning are Jon Ayers, Chief Executive Officer; Merilee Raines, Chief Financial Officer; and (Susan Ostrow), Director of Investor Relations.
IDEXX would like to preface the discussion today with a caution regarding forward-looking statements. Listeners are reminded that statements that members of IDEXX management may make on this call regarding management's future expectations and plans and IDEXX's future prospects constitute forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements can be identified by the use of words such as expects, may, anticipates, intends, would, will, plans, believes, estimates, should, and similar words and expressions. Such statements include but are not limited to statements regarding management's expectations for financial results for future periods. Listeners are reminded that actual results could differ materially from management's expectations.
Factors that could cause or contribute to such differences are described in IDEXX's quarterly report on Form 10-Q for the quarter ended September 30, 2010 and Form 10-K for the year ended December 31, 2009 in the section captioned 'Risk Factors,' which are on file with the SEC and also available on IDEXX's website, idexx.com.
In addition, any forward-looking statements represent IDEXX's estimates only as of today and should not be relied upon as representing the Company's estimates as of any subsequent date. The Company disclaims any obligation to update or revise any forward-looking statements in the future even if its estimates or expectations change.
Also, during this call, we will be discussing certain financial measures not prepared in accordance with generally accepted accounting principles or GAAP. A definition and reconciliation of these non-GAAP financial measures to related GAAP financial measures is provided in our earnings release which can be found on our website idexx.com.
Finally, we plan to end today's call by 10.00 a.m. Eastern and in order to allow broad participation in the Q&A, we ask that each participant limit his or her questions to one with one follow-up if necessary. We do appreciate you may have additional questions, so please feel free to get back into the queue and if time permits, we'll be more than happy to take your additional questions.
I would like to turn the conference over to Merilee Raines.
Merilee Raines - Corporate VP, CFO and Treasurer: Good Morning and thank you for joining our call today. I'd like to begin with a quick overview of our fourth quarter results. In our press release this morning, we reported revenues of $283.8 million, a year-to-year growth of 5% and diluted earnings per share of $0.62, a growth of 22%. Revenues excluding a roughly $2 million unfavorable impact of currency were about $5 million above our thinking at the time of our October call, driven primarily by stronger than anticipated performance in our Livestock and Poultry Diagnostics and Lab Services businesses.